Prevention of nerve growth and evoked pain with a nerve cap graft device
Sydney Borcherding(Renal Association), Lorenzo Soletti(Renal Association), Andrew D. Miller(Cornell University), Matthew D. Wood(Washington University in St. Louis), Clint D. Skillen(University of Pittsburgh), Lauren Schellhardt(Washington University in St. Louis), Bryan N. Brown(University of Pittsburgh), Pooja A. Chawla(Indo Soviet Friendship College of Pharmacy), Sai L. Pinni(Washington University in St. Louis), Anne Faust(Renal Association), Marissa N. Behun(University of Pittsburgh), Mangesh Kulkarni(University of Pittsburgh), Mark A. Mahan(University of Utah), Elena A. Demeter(Cornell University)
Cited by 2
Related Papers
Targeted Drug Delivery: Trends and Perspectives
|Current Drug Delivery|2021|136
The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection
|Journal of Virology|2022|73
Global distribution of <scp><i>Leptospira</i></scp> serovar isolations and detections from animal host species: <scp>A</scp> systematic review and online database
|Tropical Medicine & International Health|2024|42